Changing the Model for Pharma Innovation
The PharmTech website noted that at this point, for many companies, results suggest that the desire and commitment to open innovation may be there, but questions of risk and reward remain. For now, for many companies, open innovation is a work in progress, but the factors driving this trend are not going away. All indicators suggest that this risk-sharing model will continue to take root, and drive, discovery, research and development in the future.
Click here to read the full article.